BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32156885)

  • 1. [A Case of Synchronous Bilateral Neuroendocrine Ductal Carcinoma In Situ].
    Hoshi N; Abe N; Tachibana K; Noda M; Murakami Y; Okano M; Yoshida S; Abe S; Kiko Y; Hashimoto Y; Ohtake T
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2222-2224. PubMed ID: 32156885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous bilateral neuroendocrine ductal carcinoma in situ.
    Honami H; Sotome K; Sakamoto G; Iri H; Tanaka Y; Fukamachi S; Morozumi K
    Breast Cancer; 2014 Jul; 21(4):508-13. PubMed ID: 21735237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast--comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases.
    Kawasaki T; Nakamura S; Sakamoto G; Murata S; Tsunoda-Shimizu H; Suzuki K; Takahashi O; Nakazawa T; Kondo T; Katoh R
    Histopathology; 2008 Sep; 53(3):288-98. PubMed ID: 18657193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
    Tsang WY; Chan JK
    Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of neuroendocrine carcinoma in breast lesions detected by the clinical symptom of bloody nipple discharge.
    Kawasaki T; Mochizuki K; Yamauchi H; Yagata H; Kondo T; Tsunoda H; Nakamura S; Oishi N; Nakazawa T; Yamane T; Inoue A; Maruyama T; Inoue M; Inoue S; Fujii H; Katoh R
    Breast; 2012 Oct; 21(5):652-6. PubMed ID: 22397895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Neuroendocrine Ductal Carcinoma In Situ of the Breast.
    Ma BL; Rooks CO; Christopher WO; Berry SM
    Am Surg; 2023 Aug; 89(8):3526-3527. PubMed ID: 36866802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic study of breast cancer with features of endocrine ductal carcinoma-in-situ].
    Yang WT; Xu YX; Zhang TQ
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):594-7. PubMed ID: 17134566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
    Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
    Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery.
    Ohuchi N; Furuta A; Mori S
    Cancer; 1994 Aug; 74(4):1294-302. PubMed ID: 8055451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fiberoptic ductoscopy for breast cancer patients with nipple discharge.
    Shen KW; Wu J; Lu JS; Han QX; Shen ZZ; Nguyen M; Barsky SH; Shao ZM
    Surg Endosc; 2001 Nov; 15(11):1340-5. PubMed ID: 11727147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nipple Preservation in Breast Cancer Associated with Nipple Discharge.
    Chang RY; Cheung PS
    World J Surg; 2017 Jan; 41(1):176-183. PubMed ID: 27501708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-palpable ductal carcinoma in situ (DCIS) with microinvasion arising in a radial scar presenting with spiculation alone on mammograms: a case report.
    Okita A; Ohsumi S; Takashima S; Okita R; Aogi K; Saeki T; Kurita A; Nishimura R
    Breast Cancer; 2006; 13(1):107-11. PubMed ID: 16518071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paget's disease of the nipple with parenchymal ductal carcinoma in situ is associated with worse prognosis than Paget's disease alone.
    Durkan B; Bresee C; Bose S; Phillips EH; Dang CM
    Am Surg; 2013 Oct; 79(10):1009-12. PubMed ID: 24160789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male ductal carcinoma in situ: diagnosis and management of a rare disease in men.
    Tian C; Alvarado R; Kim T; Slostad J
    BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38499353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ-associated nipple discharge: a clinical marker for locally extensive disease.
    Bauer RL; Eckhert KH; Nemoto T
    Ann Surg Oncol; 1998; 5(5):452-5. PubMed ID: 9718176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease.
    Schuh ME; Nemoto T; Penetrante RB; Rosner D; Dao TL
    Arch Surg; 1986 Nov; 121(11):1303-7. PubMed ID: 3022676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous bilateral noninvasive ductal carcinoma of the male breast: a case report.
    Okada K; Kajiwara S; Tanaka H; Sakamoto G
    Breast Cancer; 2003; 10(2):163-6. PubMed ID: 12736571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
    Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
    Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
    Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
    Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.